Yes, enormous waste of money.

Craig Webster has some interesting data on how we might be investigating the wrong people, even with all those investigations being done. An excellent example of the Inverse Care Law.

What went wrong?

* Not enough evidence on what makes a difference
* Not enough agreement on how to use that evidence: should that have been local. regional, national, international protocols?
* Our usual desire for convenient analyses, rather than those that give the best clinical bangs per buck

Jonathan


On 6 Oct 2013, at 10:04, Joseph WATINE wrote:

In France vitamine D measurement in blood is now the 5th lab test in terms of costs for the "sécurité sociale": it costed almost 100.000.000 Euros in 2111, and the number of requests of vitamin D are increasing exponentially: the costs were below 40.000 Euros in 2009. At such a speed of increase, it would not be surprising that the costs would reach 150.000.000 Euros in 2013 and thus vitamin D would become  the 2nd most costly test for the collectivity in France just after blood cell counts which cost 300.000.000 Euros each year (quite stable).
I would be interested to know whether or not such a waste of collective ressources are specific to France or if the same happens elsewhere in the world, particularly in the UK.

------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/